These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36217992)

  • 21. Phenotyping CLAD after single lung transplant: Limits and prognostic assessment of the 2019 ISHLT classification system.
    Berra G; Huszti E; Levy L; Kawashima M; Fuchs E; Renaud-Picard B; Riddell P; Dias O; Rajagopala S; Ulahannan A; Ghany R; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2022 May; 41(5):599-607. PubMed ID: 35351385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of phenotype change after chronic lung allograft dysfunction onset.
    Fuchs E; Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Ghany R; Havlin J; McInnis MC; Keshavjee S; Singer LG; Tikkanen J; Chow CW; Martinu T
    Transpl Int; 2021 Dec; 34(12):2620-2632. PubMed ID: 34748217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation.
    Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Huynh RH; Saggar R; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
    Am J Transplant; 2017 May; 17(5):1294-1303. PubMed ID: 27676455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes Following Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction Following Lung Transplantation: A Single-Center Experience.
    Vazirani J; Routledge D; Snell GI; Watson D; Paraskeva M; Westall GP; Harrison SJ
    Transplant Proc; 2021; 53(1):296-302. PubMed ID: 33039145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of azithromycin and allograft rejection on the post-lung transplant microbiota.
    Spence CD; Vanaudenaerde B; Einarsson GG; Mcdonough J; Lee AJ; Johnston E; Verleden GM; Elborn JS; Dupont LJ; Van Herck A; Gilpin DF; Vos R; Tunney MM; Verleden SE
    J Heart Lung Transplant; 2020 Feb; 39(2):176-183. PubMed ID: 31812487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Socioeconomic deprivation is not associated with reduced survival of lung transplant recipients.
    Beliaev AM; Alison PM; Reddy D; O'Carroll M; Lewis C; McWilliams TJ
    J Surg Res; 2018 Oct; 230():1-6. PubMed ID: 30100023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxygenated Hemoglobin Predicts Outcome in Patients with Chronic Lung Allograft Dysfunction.
    Kahnert K; Trudzinski FC; Berger C; Munker D; Milger K; Irlbeck M; Tomasi R; Schneider C; Michel S; Ghiani A; Herth FJF; Behr J; Jörres RA; Kneidinger N
    Respiration; 2022; 101(7):638-645. PubMed ID: 35354156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation.
    Verleden GM; Dupont LJ
    Transplantation; 2004 May; 77(9):1465-7. PubMed ID: 15167610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Metapneumovirus and Parainfluenza Virus Infections in Lung Transplant Recipients: The Effects on Lung Allograft and Clinical Outcomes.
    Permpalung N; Sait AS; Bazemore K; Avery RK; Mathew J; Shah PD
    Transplantation; 2021 Dec; 105(12):2625-2631. PubMed ID: 33496558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
    Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
    Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
    J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of the preoperative prognostic nutritional index score as a predictor of chronic lung allograft dysfunction after lung transplantation: a Japanese single-institution study.
    Kanou T; Minami M; Funaki S; Ose N; Fukui E; Kimura K; Shintani Y
    Surg Today; 2021 Dec; 51(12):1946-1952. PubMed ID: 33839934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
    Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A
    J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new classification system for chronic lung allograft dysfunction.
    Verleden GM; Raghu G; Meyer KC; Glanville AR; Corris P
    J Heart Lung Transplant; 2014 Feb; 33(2):127-33. PubMed ID: 24374027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal one-year post-lung transplant spirometry is a significant predictor of increased mortality and chronic lung allograft dysfunction.
    Paraskeva MA; Borg BM; Paul E; Fuller J; Westall GP; Snell GI
    J Heart Lung Transplant; 2021 Dec; 40(12):1649-1657. PubMed ID: 34548197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative Image Analysis at Chronic Lung Allograft Dysfunction Onset Predicts Mortality.
    Weigt SS; Kim GJ; Jones HD; Ramsey AL; Amubieya O; Abtin F; Pourzand L; Lee J; Shino MY; DerHovanessian A; Stripp B; Noble PW; Sayah DM; Saggar R; Britton I; Lynch JP; Belperio JA; Goldin J
    Transplantation; 2022 Jun; 106(6):1253-1261. PubMed ID: 34534193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
    Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
    Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
    [No Abstract]   [Full Text] [Related]  

  • 39. Symptomatic Respiratory Virus Infection and Chronic Lung Allograft Dysfunction.
    Fisher CE; Preiksaitis CM; Lease ED; Edelman J; Kirby KA; Leisenring WM; Raghu G; Boeckh M; Limaye AP
    Clin Infect Dis; 2016 Feb; 62(3):313-319. PubMed ID: 26565010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.
    DerHovanessian A; Todd JL; Zhang A; Li N; Mayalall A; Finlen Copeland CA; Shino M; Pavlisko EN; Wallace WD; Gregson A; Ross DJ; Saggar R; Lynch JP; Belperio J; Snyder LD; Palmer SM; Weigt SS
    Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.